Navigation Links
Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report
Date:9/22/2009

NE: EXECUTIVE SUMMARY

  • BACKGROUND SCOPE AND METHODOLOG
  • SIZE AND GROWTH OF THE MARKET
  • KEY ISSUES AND TRENDS AFFECTING MARKET
  • LEADING COMPETITORS

CHAPTER TWO: INTRODUCTION

  • STRUCTURAL ORGANIZATION OF THE GASTROINTESTINAL SYSTEM
    • The Mouth and Salivary Glands
    • Esophagus
    • Stomach
    • Small Intestines
    • Large Intestines
    • Liver
    • Gall Bladder
    • Pancreas
  • DESCRIPTION OF THE ENDOSCOPE
    • Viewing Sheath (Scope)
    • Flexible
    • Rigid
    • Light Source
    • Fiberoptic Lighting
    • Bulbs
    • Projection Lamp
    • Power Source
    • Battery Box
    • Rheostat
    • Cameras and Video Support
    • Hand Instruments
    • Electrosurgical and Radiofrequency Instruments
    • Insufflators
    • Power and Surgical Instruments
    • Lasers
    • Other (disposables)
  • GASTROINTESTINAL DISEASES
    • Upper Gastrointestinal Diseases
      • GERD (gastroesophageal reflux disease)
      • Ulcers
    • Lower Gastrointestinal Diseases
      • Diverticulitis
      • Hemorrhoids
      • Colon Cancer
      • Irritable Bowel Syndrome (IBS)
      • Crohn's Disease
    • Upper Digestive Tract Procedures
    • Lower Digestive Tract Procedures
  • ADVANTAGES OF GASTROINTESTINAL ENDOSCOPY TREATMENT

    • '/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , "This bill provides for an unprecedente...health care about if it is not for preserving and ... it must be defeated." Charmaine Yoest ,, WA...cans United for Life Action President and CEO Dr. ... Senate by releasing the following statement: ,...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire...o eliminate onchocerciasis (river blindness) in th...e of the disease in recent years, as evidenced by ...ing mass drug administration in six endemic countr...al meeting of the American Society of Tropical Med...
(Date:11/21/2009)..., LONDON, November 21, 2009 /PRNewswire-Fir... Test Test Test Test Test Test Test Test Test Test... Test Test Test Test Test Test,Test Test Test Test... More test More test More test More test More tes...t More test More test More test More test More,tes...
(Date:11/21/2009)... Innovative medical apparel co...erence , San Clemente, Ca...aker of breakthrough medical apparel, today announ...n display at Medica 2009, a leading international ...dorf, Germany. Medelita inaugurates its men,s coll...
(Date:11/21/2009)... Eric J. Hall, president and c...on of America (AFA) issued the following statement...etection as part of the new annual wellness for Me...on and Affordable Care Act" that was introduc..., NY (PRWEB) November 21, 2009 -- Eric J. Hall, pr...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3
... Responding to increased concern...osure, Nighttime Care Centers has employed the use...ocations statewide, and this week are bringing thi... a radiological imaging tool for the evaluation of...
... Host Investor Conference Call on Monday, August 1... EDT, NEW YORK, Aug. 8 Keryx Biopharmaceuticals,... focused on the,acquisition, development and comme...today announced its results,for the second quarter...
... beating a marker for those most likely to die sud...thDay News) -- Abnormal heart rate turbulence (HRT...n death in patients with congestive heart failure,...eart failure progression, as well as sudden death ...
...les out the effect of one genetic variation , ... study adds more evidence for the link between die...udy, which included researchers at the University ...variants of a gene for angiotensinogen, a molecule...
...vers Cheer, Medication and Equipment to Young Pati...e-A-Wish Foundation, PITTSBURGH, Aug. 8 Aethon I...ain-themed "JR" autonomous mobile robot to childre...G was initially introduced at the University of Ca...
...xpress Care Clinics Provide Simple, Affordable Alt...ooms are,increasingly crowded. The number of hospi...a whopping 32 percent from 1996-2006, according to...s like the flu, earaches and strep-throat. Such co...
Other Medicine News:Health News:Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County 2Health News:Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County 3Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 2Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 3Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 4Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 5Health News:Too Much Salt Boosts Blood Pressure 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 3Health News:Report: ER Visits Skyrocket 2
(Date:11/19/2009)..., TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/...e pharmaceutical ingredients (APIs), announced tha...ound Safety Certification from,SafeBridge(R) Consu...,s,competency and proficiency in the safe handling...), and applies to specific laboratories and,produc...
(Date:11/19/2009)..., ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCa...YSE: ABT ) as one of its Most Admired Corporate ...Deal honored Abbott as its Most Admired Dealmaker...c use of acquisitions and divestitures since Janua...shaped its business portfolio with a focus on high...
(Date:11/19/2009)... , Part of International Internet Week of Acti...USNewswire/ -- The U.S. Food and Drug Administrati...ational effort, called the International Internet ...tions involving medical products. ,, (Logo: ht... ) ,, During the effort, the FDA,s Office of Cr...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 1New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 2New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 3New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 4New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 5Healthcare Trust of America Inc Completes Acquisition of 856 000 SF Greenville Hospital System Medical Office Building Portfolio 57896 1Healthcare Trust of America Inc Completes Acquisition of 856 000 SF Greenville Hospital System Medical Office Building Portfolio 57896 2Healthcare Trust of America Inc Completes Acquisition of 856 000 SF Greenville Hospital System Medical Office Building Portfolio 57896 3
...ment of Ocular Itching Associated with ...f., April 30 ISTA,Pharmaceuticals, Inc. (Nasdaq: ... preliminary analysis of its second and final Bepr...I clinical study. The U.S. multi-center,conjunctiv...set and,duration of effect of two Bepreve concentr...
...., a,biopharmaceutical company developing new ther...e 1 and 2 diabetes, announces its,achievement of a...et,Peptide (HIP). CureDM has successfully stabiliz...dose response studies indicating that the,dosage u...he native form.,HIP is a 14-amino acid human pepti...
Other Medicine Technology:ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 2ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 3ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 4CureDM's Diabetes Therapy Achieves Major Development Milestone 2
Ocular Three Mirror 10 mm Gonio
Ocular Magna View Gonio
Ocular Koeppe Diagnostic
Mcintyre Cannula
Medicine Products: